Forte Biosciences prices public offering of common stock and pre-funded warrants, raising around $75 million

From Nasdaq.: 2025-06-25 18:00:00

Forte Biosciences, Inc. has priced a public offering of 5,630,450 shares of common stock at $12.00 per share, with gross proceeds expected to total around $75 million. Certain investors also purchased pre-funded warrants for up to 619,606 shares at $11.999 per warrant. The company granted underwriters a 30-day option to purchase up to an additional 937,508 shares at the public offering price. The offering is set to close around June 26, 2025, pending customary closing conditions. Proceeds will support working capital, clinical and preclinical development of Forte’s product candidate, and general corporate purposes. On Wednesday, FBRX closed at $10.59, down 25.26%.



Read more at Nasdaq.: Forte Biosciences Prices $75 Mln Public Offering Of Common Stock And Pre-Funded Warrants